Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3726826013 | Antidiabetic therapeutic role (role) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3726827016 | Antidiabetic therapeutic role | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Antidiabetic therapeutic role (role) | est un(e) (attribut) | Therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| préparation antidiabétique | Plays role | True | Antidiabetic therapeutic role (role) | Inferred relationship | Some | |
| Product containing dapagliflozin and metformin and saxagliptin (medicinal product) | Plays role | True | Antidiabetic therapeutic role (role) | Inferred relationship | Some | |
| Product containing only dapagliflozin and metformin and saxagliptin (medicinal product) | Plays role | True | Antidiabetic therapeutic role (role) | Inferred relationship | Some | |
| Product containing only dapagliflozin and metformin and saxagliptin in oral dose form (medicinal product form) | Plays role | True | Antidiabetic therapeutic role (role) | Inferred relationship | Some | |
| Dapagliflozin- and metformin- and saxagliptin-containing product in oral dose form | Plays role | True | Antidiabetic therapeutic role (role) | Inferred relationship | Some |
Reference Sets
Canada English language reference set (foundation metadata concept)
Description inactivation indicator reference set
FHIR